Head of Advocacy & Market Development, COPD

In this highly visible leadership role, you will lead the development and execution of global advocacy and market development strategies for a key launch asset in our respiratory portfolio. Working across global, regional and local teams, you will help build scientific and clinical advocacy for IL-33 pathway science while driving healthcare system transformation initiatives designed to improve patient identification, optimize care pathways and expand access to innovative treatment approaches.

You will collaborate closely with Medical, Policy, Market Access, Digital, Commercial and local market teams to ensure strategy alignment and seamless execution across key global markets. Through strong external partnerships and expert engagement, you will help create the conditions needed to improve outcomes for patients living with COPD.

As a key member of the Global Commercial team, you will provide strategic leadership across advocacy, healthcare system change and market development initiatives that support the successful launch and long-term growth of the asset.

What You'll Do

Advocacy Leadership

• Develop and execute the global advocacy vision, strategy and operational plans to amplify the scientific and clinical narrative around IL-33 pathway innovation
• Build and maintain strong partnerships with Key External Experts (KEEs), including leadership of the Global COPD Clinical Expert Council and related respiratory disease forums
• Collaborate with Global Brand Team colleagues to develop advocacy programs, educational initiatives, speaker training and engagement activities
• Partner closely with local market advocacy leads to ensure global strategies are effectively translated into local execution plans
• Develop tailored engagement plans for priority global advocates and strengthen AstraZeneca's presence across respiratory and immunology communities

Market Development Leadership

• Define and drive the long-term global market development vision for COPD asset
• Lead the development of global market shaping strategies, tactics and assets in partnership with key markets
• Collaborate with Medical and Policy colleagues to develop healthcare system change initiatives focused on early patient identification, screening, care pathway optimization and evidence generation
• Partner with external stakeholders, including healthcare authorities, patient advocacy organizations and policymakers, to advance COPD care delivery
• Identify and coordinate external partners and vendors that support patient identification and healthcare transformation programs
• Lead cross-functional global and local teams to ensure successful planning and execution of market development initiatives
• Define and deliver compelling value propositions and service platform offerings that improve implementation and patient outcomes across priority markets

Minimum Qualifications

• Bachelor's degree, preferably in a scientific or healthcare-related discipline
• Minimum 10 years of experience within the healthcare or biopharmaceutical industry
• Demonstrated experience in Respiratory, Immunology or related therapeutic areas in the USA
• Proven success engaging and influencing external stakeholders, including KEEs, prescribers, payers and healthcare organizations
• Track record of success in global and/or local commercial leadership roles
• Strong stakeholder management and leadership skills, including experience influencing senior executives
• Experience working effectively within complex matrix organizations and across diverse cultures and geographies
• Demonstrated ability to build trusted partnerships with external organizations and senior leaders
• Successful launch experience, including advocacy development, market shaping and brand growth initiatives

Preferred Qualifications

• Advanced degree such as MBA, PhD or equivalent
• Deep understanding of respiratory disease management and healthcare system dynamics
• Experience leading healthcare transformation or market development initiatives
• Strong knowledge of policy, access and advocacy landscapes across major global markets
• Demonstrated success building external partnerships that drive meaningful healthcare change